A new national survey on cancer costs reveals that nearly all Australians diagnosed with cancer face out-of-pocket expenses, even when accessing publicly funded care. The latest findings map a financial toll that extends from diagnosis to post-treatment care and survivorship, with pressure greatest in regional areas and among First Nations communities.
Costs are not limited to medical fees. Patients and families contend with travel to appointments, accommodation for up-country care, childcare or eldercare, and the loss of income from time away from work. The combined effect can erode household finances and influence day-to-day decisions about treatment options and supportive services.
Public funding reduces some outflows, but the survey suggests many costs persist, including non-medical expenses that accumulate across the cancer journey. The financial strain may also add stress that affects mental wellbeing and overall recovery, making financial distress a public health issue as much as a personal one.
Indigenous Australians appear to experience a heavier burden, particularly in relation to blood cancers, underscoring the enduring gaps in access and outcomes. Advocates say targeted measures to lower upfront costs, improve outreach, and improve care coordination are essential to close these gaps.
What we know
- The majority of patients incur out-of-pocket costs for cancer care even when using public services.
- Costs accrue across the cancer journey—from diagnosis through treatment and aftercare.
- Indirect expenses such as travel, accommodation, and time off work add significantly to the total burden.
- There is evidence of unequal impact, with Indigenous Australians experiencing a heavier burden in some cancer areas.
- Public funding helps reduce expenses but does not fully shield households from financial strain.
What we don’t know
- The total annual cost to the health system and to households remains uncertain because many costs are difficult to capture.
- How costs influence choices about treatment types and adherence across different cancers.
- The long-term financial impact on families and survivors, including return-to-work issues.
- Whether current subsidies and exemptions effectively lessen financial distress for all patients.
- How policy changes might shift costs away from patients and what trade-offs would be involved.
Experts say the findings should prompt policymakers to consider broader supports—such as streamlined access to subsidies, travel and accommodation assistance, and stronger care coordination—to avert financial hardship while maintaining quality care. The conversation now extends beyond hospital bills to the broader context of social support, work rights, and regional health equity, as Australia navigates the cost of cancer care in the years ahead.
